Cancer Cachexia: Mediators, Signaling, and Metabolic Pathways

被引：892
|
作者：
Fearon, Kenneth C. H. [1 ]
Glass, David J. [2 ]
Guttridge, Denis C. [3 ]
机构：
[1] Univ Edinburgh, Royal Infirm, Sch Clin Sci & Community Hlth, Edinburgh EH16 4SA, Midlothian, Scotland
[2] Novartis Inst Biomed Res, Cambridge, MA 02139 USA
[3] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA
来源：
CELL METABOLISM | 2012年 / 16卷 / 02期
关键词：
SKELETAL-MUSCLE ATROPHY; TUMOR-NECROSIS-FACTOR; ACUTE-PHASE RESPONSE; UBIQUITIN LIGASE ATROGIN1/MAFBX; ADIPOSE TRIGLYCERIDE LIPASE; PROTEOLYSIS INDUCING FACTOR; FOXO TRANSCRIPTION FACTORS; SYNTHASE KINASE 3-BETA; MESSENGER-RNA LEVELS; KAPPA-B ACTIVATION;
D O I：
10.1016/j.cmet.2012.06.011
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
Cancer cachexia is characterized by a significant reduction in body weight resulting predominantly from loss of adipose tissue and skeletal muscle. Cachexia causes reduced cancer treatment tolerance and reduced quality and length of life, and remains an unmet medical need. Therapeutic progress has been impeded, in part, by the marked heterogeneity of mediators, signaling, and metabolic pathways both within and between model systems and the clinical syndrome. Recent progress in understanding conserved, molecular mechanisms of skeletal muscle atrophy/hypertrophy has provided a downstream platform for circumventing the variations and redundancy in upstream mediators and may ultimately translate into new targeted therapies.
引用
收藏
页码：153 / 166
页数：14
相关论文
共 50 条
  • [41] The epidemiology of sex steroid hormones and their signaling and metabolic pathways in the etiology of prostate cancer
    Platz, EA
    Giovannucci, E
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2004, 92 (04): : 237 - 253
  • [42] Oncogenic metabolic reprogramming in breast cancer: focus on signaling pathways and mitochondrial genes
    Malayil, Rhuthuparna
    Chhichholiya, Yogita
    Vasudeva, Kanika
    Singh, Harsh Vikram
    Singh, Tashvinder
    Singh, Sandeep
    Munshi, Anjana
    MEDICAL ONCOLOGY, 2023, 40 (06)
  • [43] Liver Inflammation and Metabolic Signaling in ApcMin/+ Mice: The Role of Cachexia Progression
    Narsale, Aditi A.
    Enos, Reilly T.
    Puppa, Melissa J.
    Chatterjee, Saurabh
    Murphy, E. Angela
    Fayad, Raja
    O'Pena, Majorette
    Durstine, J. Larry
    Carson, James A.
    PLOS ONE, 2015, 10 (03):
  • [44] Metabolic pathways and physiological and pathological significances of lysolipid phosphate mediators
    Tokumura, A
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2004, 92 (05) : 869 - 881
  • [45] Metabolic Signatures Imaged in Cancer-Induced Cachexia
    Penet, Marie-France
    Gadiya, Mayur M.
    Krishnamachary, Balaji
    Nimmagadda, Sridhar
    Pomper, Martin G.
    Artemov, Dmitri
    Bhujwalla, Zaver M.
    CANCER RESEARCH, 2011, 71 (22) : 6948 - 6956
  • [46] Metabolic Reprogramming in Adipose Tissue During Cancer Cachexia
    Weber, Bahar Zehra Camurdanoglu
    Arabaci, Dilsad H.
    Kir, Serkan
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [47] Cancer Cachexia: Metabolic Changes In Carbohydrate Metabolism Of The Liver
    Ramey, Sarah
    Rosa-Caldwell, Megan E.
    Brown, Jacob L.
    Perry, Richard A.
    Haynie, Wesley A.
    Caldwell, Aaron R.
    Washington, Tyrone A.
    Wiggs, Michael P.
    Greene, Nicholas P.
    MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2018, 50 (05): : 212 - 212
  • [48] Systemic metabolic changes in mouse models of cancer cachexia
    Aoki, Masahiro
    Kojima, Yasushi
    Soga, Tomoyoshi
    CANCER SCIENCE, 2018, 109 : 144 - 144
  • [49] Metabolic, Inflammatory, and Molecular Impact of Cancer Cachexia on the Liver
    Goncalves, Daniela Caetano
    Gomes, Silvio Pires
    Seelaender, Marilia
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (22)
  • [50] Mechanisms of metabolic dysfunction in cancer-associated cachexia
    Petruzzelli, Michele
    Wagner, Erwin F.
    GENES & DEVELOPMENT, 2016, 30 (05) : 489 - 501
12345